Literature DB >> 25523813

Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.

Clifford L Eastman1, Jason S Fender1, Nancy R Temkin2, Raimondo D'Ambrosio3.   

Abstract

Conventionally developed antiseizure drugs fail to control epileptic seizures in about 30% of patients, and no treatment prevents epilepsy. New etiologically realistic, syndrome-specific epilepsy models are expected to identify better treatments by capturing currently unknown ictogenic and epileptogenic mechanisms that operate in the corresponding patient populations. Additionally, the use of electrocorticography permits better monitoring of epileptogenesis and the full spectrum of acquired seizures, including focal nonconvulsive seizures that are typically difficult to treat in humans. Thus, the combined use of etiologically realistic models and electrocorticography may improve our understanding of the genesis and progression of epilepsy, and facilitate discovery and translation of novel treatments. However, this approach is labor intensive and must be optimized. To this end, we used an etiologically realistic rat model of posttraumatic epilepsy, in which the initiating fluid percussion injury closely replicates contusive closed-head injury in humans, and has been adapted to maximize epileptogenesis and focal non-convulsive seizures. We obtained week-long 5-electrode electrocorticography 1 month post-injury, and used a Monte-Carlo-based non-parametric bootstrap strategy to test the impact of electrode montage design, duration-based seizure definitions, group size and duration of recordings on the assessment of posttraumatic epilepsy, and on statistical power to detect antiseizure and antiepileptogenic treatment effects. We found that use of seizure definition based on clinical criteria rather than event duration, and of recording montages closely sampling the activity of epileptic foci, maximize the power to detect treatment effects. Detection of treatment effects was marginally improved by prolonged recording, and 24h recording epochs were sufficient to provide 80% power to detect clinically interesting seizure control or prevention of seizures with small groups of animals. We conclude that appropriate electrode montage and clinically relevant seizure definition permit convenient deployment of fluid percussion injury and electrocorticography for epilepsy therapy development.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug development; Focal epilepsy; Non-convulsive seizure; Pharmacoresistance; Preclinical drug screening; Statistical power analysis

Mesh:

Year:  2014        PMID: 25523813      PMCID: PMC4327986          DOI: 10.1016/j.expneurol.2014.12.010

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  42 in total

Review 1.  Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).

Authors:  Meir Bialer; Svein I Johannessen; René H Levy; Emilio Perucca; Torbjörn Tomson; H Steve White
Journal:  Epilepsy Res       Date:  2010-12       Impact factor: 3.045

2.  Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).

Authors:  Robert S Fisher; Walter van Emde Boas; Warren Blume; Christian Elger; Pierre Genton; Phillip Lee; Jerome Engel
Journal:  Epilepsia       Date:  2005-04       Impact factor: 5.864

3.  Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia.

Authors:  Tracy Butler; Masanori Ichise; Andrew F Teich; Elizabeth Gerard; Joseph Osborne; Jacqueline French; Orrin Devinsky; Ruben Kuzniecky; Frank Gilliam; Fahad Pervez; Frank Provenzano; Stanley Goldsmith; Shankar Vallabhajosula; Emily Stern; David Silbersweig
Journal:  J Neuroimaging       Date:  2011-01-11       Impact factor: 2.486

4.  Seizure frequency in pilocarpine-treated rats is independent of circadian rhythm.

Authors:  Rika Bajorat; Marleen Wilde; Tina Sellmann; Timo Kirschstein; Rüdiger Köhling
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

5.  Impact of injury location and severity on posttraumatic epilepsy in the rat: role of frontal neocortex.

Authors:  Giulia Curia; Michael Levitt; Jason S Fender; John W Miller; Jeffrey Ojemann; Raimondo D'Ambrosio
Journal:  Cereb Cortex       Date:  2010-11-26       Impact factor: 5.357

6.  Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice.

Authors:  Kerry-Ann A Stewart; Karen S Wilcox; Robert S Fujinami; H Steve White
Journal:  J Neuropathol Exp Neurol       Date:  2010-12       Impact factor: 3.685

7.  Mild passive focal cooling prevents epileptic seizures after head injury in rats.

Authors:  Raimondo D'Ambrosio; Clifford L Eastman; Felix Darvas; Jason S Fender; Derek R Verley; Federico M Farin; Hui-Wen Wilkerson; Nancy R Temkin; John W Miller; Jeffrey Ojemann; Steven M Rothman; Matthew D Smyth
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Post-traumatic epilepsy following fluid percussion injury in the rat.

Authors:  Raimondo D'Ambrosio; Jared P Fairbanks; Jason S Fender; Donald E Born; Dana L Doyle; John W Miller
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

9.  Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat.

Authors:  Grant S Goodrich; Anatoli Y Kabakov; Mustafa Q Hameed; Sameer C Dhamne; Paul A Rosenberg; Alexander Rotenberg
Journal:  J Neurotrauma       Date:  2013-07-25       Impact factor: 5.269

10.  Complex partial seizures of frontal lobe origin.

Authors:  P D Williamson; D D Spencer; S S Spencer; R A Novelly; R H Mattson
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

View more
  5 in total

1.  2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Authors:  Dennis Dlugos; Greg Worrell; Kathryn Davis; William Stacey; Jerzy Szaflarski; Andres Kanner; Sridhar Sunderam; Mike Rogawski; Patrice Jackson-Ayotunde; Tobias Loddenkemper; Beate Diehl; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

2.  Methodological standards and interpretation of video-electroencephalography in adult control rodents. A TASK1-WG1 report of the AES/ILAE Translational Task Force of the ILAE.

Authors:  Shilpa D Kadam; Raimondo D'Ambrosio; Venceslas Duveau; Corinne Roucard; Norberto Garcia-Cairasco; Akio Ikeda; Marco de Curtis; Aristea S Galanopoulou; Kevin M Kelly
Journal:  Epilepsia       Date:  2017-11       Impact factor: 5.864

3.  The progression of electrophysiologic abnormalities during epileptogenesis after experimental traumatic brain injury.

Authors:  Aylin Y Reid; Anatol Bragin; Christopher C Giza; Richard J Staba; Jerome Engel
Journal:  Epilepsia       Date:  2016-08-06       Impact factor: 5.864

4.  Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.

Authors:  Aristea S Galanopoulou; Wolfgang Löscher; Laura Lubbers; Terence J O'Brien; Kevin Staley; Annamaria Vezzani; Raimondo D'Ambrosio; H Steve White; Harald Sontheimer; John A Wolf; Roy Twyman; Vicky Whittemore; Karen S Wilcox; Brian Klein
Journal:  Epilepsia Open       Date:  2021-05-06

Review 5.  Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

Authors:  Pavel Klein; Raymond Dingledine; Eleonora Aronica; Christophe Bernard; Ingmar Blümcke; Detlev Boison; Martin J Brodie; Amy R Brooks-Kayal; Jerome Engel; Patrick A Forcelli; Lawrence J Hirsch; Rafal M Kaminski; Henrik Klitgaard; Katja Kobow; Daniel H Lowenstein; Phillip L Pearl; Asla Pitkänen; Noora Puhakka; Michael A Rogawski; Dieter Schmidt; Matti Sillanpää; Robert S Sloviter; Christian Steinhäuser; Annamaria Vezzani; Matthew C Walker; Wolfgang Löscher
Journal:  Epilepsia       Date:  2017-12-15       Impact factor: 5.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.